175

Dermatology
Focus on skin health and related diseases.
Sub Categories on Dermatology
{{items.name}}
Latest Articles
FDA approves Zoryve for atopic dermatitis

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p
Updated on: July 17,2024 0
FDA approves Zoryve for atopic dermatitis

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p
Updated on:July 17,2024 0
Prevalence of skin cancer varies for sexual minority, heterosexual adults

Prevalence of skin cancer varies for sexual minority, heterosexual adults

by Elana GotkineWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published
Updated on: July 23,2024 0
Prevalence of skin cancer varies for sexual minority, heterosexual adults

Prevalence of skin cancer varies for sexual minority, heterosexual adults

by Elana GotkineWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published
Updated on:July 23,2024 0
Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432
Updated on: July 31,2024 0
Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432
Updated on:July 31,2024 0
Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

by Elana GotkineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea comp
Updated on: August 06,2024 0
Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

by Elana GotkineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea comp
Updated on:August 06,2024 0
Expert offers tips to control excessive sweating

Expert offers tips to control excessive sweating

by Ernie MundellSweating in the heat, while exercising or when under stress is natural and expected.But if you find yourself excessively sweating in the absence of those conditions, you might have a c
Updated on: August 07,2024 0
Expert offers tips to control excessive sweating

Expert offers tips to control excessive sweating

by Ernie MundellSweating in the heat, while exercising or when under stress is natural and expected.But if you find yourself excessively sweating in the absence of those conditions, you might have a c
Updated on:August 07,2024 0
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Updated on: August 14,2024 0
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Updated on:August 14,2024 0
Understanding Mpox: Symptoms, Transmission, and Prevention

Understanding Mpox: Symptoms, Transmission, and Prevention

Mpox is a serious viral illness that requires prompt diagnosis and treatment. Preventive measures, including vaccination and self-care practices, are essential to control the spread of the virus.
Updated on: August 19,2024 0
Understanding Mpox: Symptoms, Transmission, and Prevention

Understanding Mpox: Symptoms, Transmission, and Prevention

Mpox is a serious viral illness that requires prompt diagnosis and treatment. Preventive measures, including vaccination and self-care practices, are essential to control the spread of the virus.
Updated on:August 19,2024 0
More News
Categories
Anesthesiology & Pain
Cardiology & Vascular surgery
Dermatology
Diabetes & Endocrinology
ENT & HN Surgery
Emergency Medicine & ICU
Epidemiology & Public Health
Family Medicine
Gastroenterology
Geriatrics
Hepatobiliary & Pancreas Surgery
Immunology & Rheumatology
Nephrology & Urology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Psychiatry
Pulmonology
Reproduction
Stomatology
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
APP
Medicine.net
Meditionary
PanWriting
PanDraw